Merit Medical Systems Inc. (MMSI) Tops Q4 EPS by 12c; Guides FY23

Merit Medical Systems Inc. (NASDAQ: MMSI) reported Q4 EPS of $0.79, $0.12 better than the analyst estimate of $0.67. Revenue for the quarter came in at $293.4 million versus the consensus estimate of $290.15 million.

GUIDANCE:

Merit Medical Systems Inc. sees FY2023 EPS of $2.80-$2.89, versus the consensus of $2.83. Merit Medical Systems Inc. sees FY2023 revenue of $1.194-1.21 billion, versus the consensus of $1.2 billion.

For earnings history and earnings-related data on Merit Medical Systems Inc. (MMSI) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Pfizer lung cancer drug misses survival goal in Phase 3 trial
• NVE Corporation names new CEO and expands board to seven members